Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

41.18
Delayed Data
As of Aug 28
 -0.85 / -2.02%
Today’s Change
30.13
Today|||52-Week Range
52.58
-19.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash8.0M80.9M8.9M30.7M
 
 
 
 
 
Short Term Investment Cash6.4M3.7M-1.7M21.8M
 
 
 
 
 
Cash & Short Term Investments24.5M114.2M101.5M90.8M
 
 
 
 
 
 
ReceivablesReceivables261.0K2.9M1.6M1.7M
 
 
 
 
 
 
InventoriesInventories0.000.00------
 
Current AssetsOther Current Assets369.0K604.0K1.6M15.5M
 
 
 
 
 
Current Assets25.1M117.7M104.7M108.0M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross5.2M5.1M5.5M5.9M
 
 
 
 
 
Depreciation-4.6M-4.5M-4.3M-4.1M
 
 
 
 
 
Other Assets27.0K2.2M0.000.00
 
 
 
Total Assets26.1M122.6M117.0M155.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable566.0K1.9M1.5M1.9M
 
 
 
 
 
Accrued Expenses755.0K2.6M2.0M1.6M
 
 
 
 
 
Other Current Liabilities755.0K2.6M2.0M1.6M
 
 
 
 
 
Other Liabilities2.1M5.7M4.5M4.7M
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes0.000.000.00-4.2M
 
 
Other Liabilities2.0M2.5M1.9M1.7M
 
 
 
 
 
Total Liabilities4.1M8.2M6.5M6.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock153.9M0.000.00202.0K
 
 
 
Common Equity-132.0M114.4M110.5M148.7M
 
 
 
 
 
Total Shareholder Equity22.0M114.4M110.5M148.9M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding16.8M16.8M17.9M18.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.